EW
Edwards Lifesciences CorpCompany with tickers: EW
CIK
1099800
CUSIP
28176E108
Shares Outstanding
575,800,000
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $1,648,600,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Cost of Revenue | — | ||||
| Gross Profit | $1,286,000,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Operating Expenses | — | ||||
| Research & Development | $263,300,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Operating Income | $477,600,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Net Income | $380,700,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Basic) | $0.66 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Diluted) | $0.66 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |